Patents Assigned to Hutchison MediPharma Enterprises Ltd.
  • Andrographolide and analogues as inhibitors of TNF? and IL-1? expression
    Patent number: 7625945
    Abstract: This invention relates to a method of inhibiting the expression of TNF? or IL-1? with a compound of the following formula: wherein R1 and R2 are defined herein. It also relates to is a method of treating inflammatory bowel disease with such a compound.
    Type: Grant
    Filed: March 11, 2005
    Date of Patent: December 1, 2009
    Assignee: Hutchison MediPharma Enterprises Ltd.
    Inventors: Xiaoqiang Yan, Tao Wang, Zhiming Ma, Ke Pan, Weihan Zhang, Jianrong Hong, Jeff Duan, Yu Cai